Table 1.

Patient demographics and prior therapies

Demographics and patient characteristicsAll patients N = 48
Sex, n (%)
 Male21 (44)
 Female27 (56)
Age, years, median (range)65.7 (41–84)
Race, n (%)
 White38 (79)
 Black7 (15)
 Asian2 (4)
 Other1 (2)
ECOG, n (%)
 013 (27)
 134 (71)
 21 (2)
Prior therapies
 Any prior therapy, n (%)48 (100)
 Transplant, n (%)25 (52)
 Bortezomib, n (%)37 (77)
 IMiD, n (%)42 (88)
 Bortezomib or IMiD, n (%)48 (100)
 Prior treatments, median (range)3 (1–10)
Multiple myeloma status, n (%)
 Progressive disease36 (75)
 Refractory12 (25)

Abbreviations: ECOG, Eastern Cooperative Oncology Group; IMiD, immunomodulatory drug.